Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision note updated to v3.5.0, replacing the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-21T01:18:13.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3. The prior revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:11:24.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 on the page, reflecting an internal update. No user-facing content or functionality appears to be affected.
    Difference
    0.1%
    Check dated 2026-02-13T12:39:17.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no changes to study data or core page content.
    Difference
    0.1%
    Check dated 2026-02-05T15:28:34.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Glossary is now shown by default (Show glossary). The labels related to QC criteria and FEAR Act data have standardized capitalization (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision tag updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-29T06:28:18.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed, indicating a minor maintenance update to the site. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T02:59:19.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.